| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Btk inhibitor 2 |
Btk inhibitor 2 |
1558036-85-3 |
详细
|
| BMS-935177 |
1231889-53-4 |
1231889-53-4 |
详细
|
| Vecabrutinib |
维卡布鲁替尼 |
1510829-06-7 |
详细
|
| SB 290157 (trifluoroacetate salt) |
1140525-25-2 |
1140525-25-2 |
详细
|
| Cinacalcet |
西那卡塞 |
226256-56-0 |
详细
|
| Cinacalcet HCl |
盐酸甲状旁腺激素 |
364782-34-3 |
详细
|
| Suvecaltamide |
MK-8998 |
953778-58-0 |
详细
|
| NS-638 |
150493-34-8 |
150493-34-8 |
详细
|
| trans-Ned 19 |
化合物 T12205L |
1354235-96-3 |
详细
|
| TTA-Q6 |
910484-28-5 |
910484-28-5 |
详细
|
| TTA-Q6(isomer) |
TTA-Q6(isomer) |
910484-32-1 |
详细
|
| Sunvozertinib |
DZD 9008 |
2370013-12-8 |
详细
|
| (S)-Sunvozertinib |
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]- |
2370013-49-1 |
详细
|
| Luxeptinib |
CG-806 |
1616428-23-9 |
详细
|
| Mirogabalin besylate |
10928苯磺酸盐 |
1138245-21-2 |
详细
|
| Drotaverine hydrochloride |
盐酸屈他维林 |
985-12-6 |
详细
|
| Pinaverium bromide |
匹维溴铵 |
53251-94-8 |
详细
|
| BMS-986142 |
BMS986142 |
1643368-58-4 |
详细
|
| Branebrutinib |
BMS-986195 |
1912445-55-6 |
详细
|
| ARQ 531 |
ARQ-531 |
2095393-15-8 |
详细
|
| BTK inhibitor 10 |
BTK inhibitor 10 |
2241732-30-7 |
详细
|
| Orelabrutinib |
奥布替尼 |
1655504-04-3 |
详细
|
| Pirtobrutinib |
LOXO-305 |
2101700-15-4 |
详细
|
| (R)-Pirtobrutinib |
(R)-PIRTOBRUTINIB |
2101700-14-3 |
详细
|
| SJF620 |
SJF620 |
2376187-16-3 |
详细
|
| TL-895 |
2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]- |
1415823-49-2 |
详细
|
| BIIB091 |
1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-[(5R)-2,3,4,5-TETRAHYDRO-8-[2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]-4-PYRIMIDINYL]-2-(3-OXETANYL)-1H-2-BENZ |
2247614-80-6 |
详细
|
| Acalabrutinib |
阿卡替尼 |
1420477-60-6 |
详细
|
| Spebrutinib |
AVL292 |
1202757-89-8 |
详细
|
| RN486 |
RN 486 |
1242156-23-5 |
详细
|
| ONO-4059 analog |
6-氨基-7,9-二氢-9-[(3S)-1-(1-氧代-2-丙烯-1-基)-3-哌啶基]-7-(4-苯氧基苯基)-8H-嘌呤-8-酮 |
1351635-67-0 |
详细
|
| Fenebrutinib |
GDC-0853 |
1434048-34-6 |
详细
|
| PCI 29732 |
4-氨基-1-环戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶 |
330786-25-9 |
详细
|
| BIIB068 |
BIIB068 |
1798787-27-5 |
详细
|
| TAK-020 |
化合物TAK-020 |
1627603-21-7 |
详细
|
| Tirabrutinib |
替拉鲁替尼 |
1351636-18-4 |
详细
|
| Fantofarone |
泛托法隆 |
114432-13-2 |
详细
|
| Tirabrutinib hydrochloride |
ONO-4059 (HYDROCHLORIDE) |
1439901-97-9 |
详细
|
| Flunisolide |
氟尼缩松 |
3385-03-3 |
详细
|
| DPH |
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 |
484049-04-9 |
详细
|
| BODIPY564/570carboxylicacid |
BODIPY564/570羧酸 |
150173-89-0 |
详细
|
| BODIPYFLcarboxylicacid |
BODIPYFL羧酸 |
165599-63-3 |
详细
|
| BODIPYFLNHSester |
BODIPYFLNHS活化酯 |
146616-66-2 |
详细
|
| BODIPYR6Gcarboxylicacid |
BODIPYR6G羧酸 |
174881-57-3 |
详细
|
| BDP TMR NHS ester |
BODIPYTMRNHS活化酯 |
485397-12-4 |
详细
|
| MK-5046 |
5MG |
1022152-70-0 |
详细
|
| Neuromedin B (porcine) |
GLY-ASN-LEU-TRP-ALA-THR-GLY-HIS-PHE-MET-NH2 |
87096-84-2 |
详细
|
| Lys-[Des-Arg9]Bradykinin TFA |
化合物LYS-[DES-ARG9]BRADYKININ,TFA |
2763588-90-3 |
详细
|
| Des-Arg9]-Bradykinin acetate |
[DES-ARG9]-缓激肽 乙酸盐 水合物 |
23827-91-0 |
详细
|
| Bradykinin (1-7) |
舒缓激肽片段1-7 |
23815-87-4 |
详细
|
| Bradykinin (1-5) |
ARG-PRO-PRO-GLY-PHE |
23815-89-6 |
详细
|
| Bradykinin (2-9) |
Bradykinin (2-9) |
16875-11-9 |
详细
|
| Ibrutinib-biotin |
1599432-18-4 |
1599432-18-4 |
详细
|
| Dihydrodiol-Ibrutinib |
依鲁替尼代谢物 |
1654820-87-7 |
详细
|
| (±)-Zanubrutinib |
(±)-赞鲁替尼 |
1633350-06-7 |
详细
|
| Zanubrutinib |
泽布替尼 |
1691249-45-2 |
详细
|
| Pitavastatin-d4 |
Pitavastatin-d4 |
2070009-71-9 |
详细
|
| ASTX660 |
ASTX660 |
1799328-86-1 |
详细
|
| APG-1387 |
APG-1387 |
1570231-89-8 |
详细
|
| NSC 15364 |
1,3-二(4-氨基苯基)脲 |
4550-72-5 |
详细
|
| Azilsartan |
阿齐沙坦 |
147403-03-0 |
详细
|
| Amiloride hydrochloride |
盐酸阿米洛利 |
2016-88-8 |
详细
|
| Omaveloxolone |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
详细
|
| Bosutinib hydrate |
博舒替尼一水化合物 |
918639-08-4 |
详细
|
| Nilotinib-d6 |
尼罗替尼-D6 |
1268356-17-7 |
详细
|
| BV02 |
2-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID |
292870-53-2 |
详细
|
| Asciminib |
ABL-001 |
1492952-76-7 |
详细
|
| Asciminib hydrochloride |
阿思尼布盐酸盐 |
2119669-71-3 |
详细
|
| LXH254 |
LXH254 |
1800398-38-2 |
详细
|
| Ponatinib-d8 |
纳替尼-D8 |
1562993-37-6 |
详细
|
| GMB-475 |
GMB-475 |
2490599-18-1 |
详细
|
| Rebastinib |
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 |
1020172-07-9 |
详细
|
| Olverembatinib |
GZD824 |
1257628-77-5 |
详细
|
| Olverembatinib dimesylate |
GZD824DIMESYLATE |
1421783-64-3 |
详细
|
| GNF-5 |
GNF-5 |
778277-15-9 |
详细
|
| Bafetinib |
巴氟替尼 |
859212-16-1 |
详细
|
| XL228 |
N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺 |
898280-07-4 |
详细
|
| (S)-ML753286 |
1699720-85-8 |
1699720-85-8 |
详细
|
| ML230 |
ML233 |
1776055-05-0 |
详细
|
| YHO-13351 free base |
912288-64-3 |
912288-64-3 |
详细
|
| Ac32Az19 |
|
2760674-72-2 |
详细
|
| Elacridar |
依克立达 |
143664-11-3 |
详细
|
| PTC209 HBr |
PTC-209HBR |
1217022-63-3 |
详细
|
| BODIPY558/568NHSester |
BODIPY558/568NHS活化酯 |
150173-73-2 |
详细
|
| BODIPY558/568carboxylicacid |
BODIPY558/568羧酸 |
150173-72-1 |
详细
|
| (E)-Ferulic acid-d3 |
阿魏酸-D3 |
860605-59-0 |
详细
|
| Mirodenafil dihydrochloride |
米罗那非二盐酸盐 |
862189-96-6 |
详细
|
| S116836 |
化合物 T24751 |
1257628-57-1 |
详细
|
| Lometrexol hydrate |
洛美曲索水合物 |
1435784-14-7 |
详细
|
| Z-Asp-CH2-DCB |
CASPASE-1 INHIBITOR V ;Z-VAL-ALA-ASP(OME)-FLUOROMETHYLKETONE |
153088-73-4 |
详细
|
| Estramustine phosphate sodium |
雌莫司汀磷酸钠 |
52205-73-9 |
详细
|
| Takinib |
1111556-37-6 |
1111556-37-6 |
详细
|
| Eragidomide |
CC-90009 |
1860875-51-9 |
详细
|
| Bz 423 |
216691-95-1 |
216691-95-1 |
详细
|
| PDK4-IN-1 hydrochloride |
PDK4-IN-1 HYDROCHLORIDE |
2310262-11-2 |
详细
|
| RRx-001 |
RRX-001 |
925206-65-1 |
详细
|
| BMS-1 |
PD-1 |
1675201-83-8 |
详细
|
| LDN-57444 |
LDN-57444 |
668467-91-2 |
详细
|
| OR-1896 |
左西孟旦杂质 |
220246-81-1 |
详细
|
| Eprenetapopt |
APR-246 |
5291-32-7 |
详细
|